Cefprozil and Heart rate increased - a phase IV clinical study of FDA data

Summary:

Heart rate increased is reported as a side effect among people who take Cefprozil (cefprozil), especially for people who are female, 40-49 old, also take Xolair, and have Asthma.

The phase IV clinical study analyzes which people have Heart rate increased when taking Cefprozil. It is created by eHealthMe based on reports of 1,051 people who have side effects when taking Cefprozil from the FDA, and is updated regularly.

What is Cefprozil?

Cefprozil has active ingredients of cefprozil. It is often used in sinusitis. eHealthMe is studying from 1,103 Cefprozil users. Check the latest studies of Cefprozil.

What is Heart rate increased?

Heart rate increased is found to be associated with 2,386 drugs and 3,212 conditions by eHealthMe. Check the latest studies of Heart rate increased.

On Aug, 04, 2026

1,051 people reported to have side effects when taking Cefprozil.
Among them, 62 people (5.9%) have Heart rate increased.

Could Cefprozil cause Heart rate increased?

Among these 62 people:

What is the gender of people who have Heart rate increased when taking Cefprozil? *

female: 50.85 %
male: 49.15 %

What is the age of people who have Heart rate increased when taking Cefprozil? *

What are other drugs people take besides Cefprozil? *

What are other side effects people have besides Heart rate increased? *

Oropharyngeal Pain: 37 people, 59.68%
Cough: 35 people, 56.45%
Fatigue (feeling of tiredness): 30 people, 48.39%
Forced Expiratory Volume Decreased (decreased lung expired air volume): 28 people, 45.16%
Malaise (a feeling of general discomfort or uneasiness): 26 people, 41.94%
Drug Hypersensitivity: 26 people, 41.94%
Productive Cough: 25 people, 40.32%
The Flu (the flu is caused by an influenza virus): 24 people, 38.71%
Dyspnea (difficult or laboured breathing): 24 people, 38.71%
Obstructive Airways Disorder (a progressive disease that makes it hard to breathe): 23 people, 37.10%

What are the existing conditions these people have? *

Asthma: 35 people, 56.45%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 16 people, 25.81%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 16 people, 25.81%
Anaemia (lack of blood): 8 people, 12.90%
Streptococcal Infection: 6 people, 9.68%
Nasopharyngitis (inflammation of the nasopharynx): 6 people, 9.68%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 8.06%
Pneumonia: 4 people, 6.45%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 4 people, 6.45%
Cellulitis (infection under the skin): 4 people, 6.45%

* Approximation only. Some reports may have incomplete information.

Do you take Cefprozil and have Heart rate increased?

- Check whether Heart rate increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cefprozil:

Cefprozil (1,103 reports)

Browse all side effects of Cefprozil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Heart rate increased:

Heart rate increased (2,386 drugs)

Browse all the conditions that are associated with Heart rate increased:

Heart rate increased (3,212 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on cefprozil (the active ingredients of Cefprozil) and Cefprozil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.